MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Association between emotional/cognitive factors and postural control in individuals with Parkinson’s disease and freezing of gait

    CN. de Oliveira, ACL. de Lima-Pardini, C. Souza, R. Marquesini, LA. Teixeira, CS. Silva-Batista, DB. Coelho (Sp, Brazil)

    Objective: To investigate the association between emotional/cognitive factors and the parameters of postural control of patients with Parkinson’s disease (PD) and freezing of gait (FoG).…
  • MDS Virtual Congress 2021

    Cognitive Diagnostics for Parkinson’s Disease: A Novel Digitized Approach Using Non-Motor Symptoms

    A. Murrar, M. Abu Snineh, M. Herzallah (Jerusalemp, State of Palestine)

    Objective: To evaluate the validity and reliability of cognitive markers to identify patients with PD Background: Parkinson’s disease (PD) is classically diagnosed by the clinical…
  • MDS Virtual Congress 2021

    THE ABILITY OF PATIENTS WITH PARKINSON’S DISEASE TO RECOGNIZE MASKED FACES DURING COVID-19 PANDEMIC

    S. Tezcan Aydemir, M. Kuzu Kumcu, N. Durmaz çelik, B. Bakirarar, S. özkan, M. Akbostancı (Ankara, Turkey)

    Objective: This study aims to evaluate the effect of using masks on face recognition ability in Patients with Parkinson’s disease (PwP). Background: Patients with Parkinson’s…
  • MDS Virtual Congress 2021

    Parkin Mutation and Deep Brain Stimulation

    E. Erdil, H. Omercikoglu, F. Bayraklı, D. Gunal (Istanbul, Turkey)

    Objective: To investigate the clinical features of Parkin mutated patients who undergone subthalamic brain stimulation (DBS group) and pharmalogically treated only (Non-DBS group). Background: The…
  • MDS Virtual Congress 2021

    Nanopore single-molecule sequencing to investigate mitochondrial DNA CpG methylation in Parkinson’s disease

    T. Lüth, K. Wasner, C. Klein, S. Schaake, R. Tse, S. Pereira, J. Laß, L. Sinkkonen, A. Grünewald, J. Trinh (Lübeck, Germany)

    Objective: Nanopore whole-genome sequencing of native DNA to investigate mitochondrial DNA (mtDNA) CpG methylation from patients with Parkinson’s disease (PD) and healthy controls. Background: PD…
  • MDS Virtual Congress 2021

    Genetic factors associated with dementia in Parkinson’s disease in the Parkinson’s Incidence Cohorts Collaboration (PICC)

    A. Szwedo, I. Dalen, M. Camacho, R. Lawson, D. Bäckström, L. Forsgren, C. Tzoulis, OB. Tysnes, A. Macleod, C. Counsell, C. Williams-Gray, KF. Pedersen, G. Alves, J. Maple-Grødem (Stavanger, Norway)

    Objective: To evaluate the effect of genetic variants in β-glucocerebrosidase (GBA), apolipoprotein E (APOE), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA) loci on the risk…
  • MDS Virtual Congress 2021

    MicroRNAs as a potential biomarker of Parkinson’s disease

    N. Ardashirova, A. Protopopova, N. Abramycheva, E. Fedotova, S. Illarioshkin (Moscow, Russian Federation)

    Objective: Our study was aimed at analyzing the role of microRNA as a potential biomarker of PD. Background: A substantial part of cases of Parkinson’s…
  • MDS Virtual Congress 2021

    Double labeling alpha-synuclein in labial minor salivary glands in Parkinson’s disease and idiopathic RBD patients

    G. Mangone, M. Houot, S. Boluda Casas, A. Chalancon, A. Prigent, D. Seilhean, JC. Corvol, M. Vidailhet, C. Duyckaerts, B. Degos (Paris, France)

    Objective: To investigate the presence of α-Syn immunostaining in minor salivary gland biopsies (MSGB) from patients with idiopathic Parkinson's disease (PD), idiopathic Rapid Eye Movement…
  • MDS Virtual Congress 2021

    Functional connectivity as an early marker of indication for deep brain stimulation treatment in Parkinson’s disease (PD)

    L. Albano, F. Agosta, S. Basaia, C. Cividini, T. Stojkovic, E. Sarasso, I. Stankovic, A. Tomic, V. Markovic, E. Stefanova, P. Mortini, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To identify functional neuroimaging patterns anticipating the clinical indication for deep brain stimulation (DBS) in patients with PD. Background: DBS has become a well-established…
  • MDS Virtual Congress 2021

    Resting-state connectivity predictors for prefrontal cortex activity during walking in Parkinson’s disease.

    H. Ding, I. Maidan, A. Droby, J. Hausdorff, A. Mirelman, S. Groppa, M. Muthuraman (Mainz, Germany)

    Objective: Investigating whether resting-state brain connectivity can predict prefrontal cortex activity (PFCA) during walking for patients with Parkinson's disease (PD) and reflect the benefits of…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley